{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sdtmct-2015-06-26", "title": "SDTM Controlled Terminology Package 22 Effective 2015-06-26", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/sdtmct-2015-03-27/codelists/C96780", "title": "CDISC SDTM Tumor and Lesion Identification Result Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/sdtmct/codelists/C96780", "title": "Version-agnostic anchor resource for codelist C96780", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sdtmct-2015-06-26/codelists/C96780", "title": "CDISC SDTM Tumor and Lesion Identification Result Terminology", "type": "Code List"}}, "conceptId": "C96780", "definition": "Terminology relevant to tumor and lesion identification results.", "extensible": "true", "name": "Tumor and Lesion Identification Results", "preferredTerm": "CDISC SDTM Tumor and Lesion Identification Result Terminology", "submissionValue": "TUMIDENT", "synonyms": ["Tumor and Lesion Identification Results"], "terms": [{"conceptId": "C14172", "definition": "For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health. (NCI)", "preferredTerm": "Benign", "submissionValue": "BENIGN", "synonyms": ["Benign"]}, {"conceptId": "C103416", "definition": "The identification of a tumor, lesion, or site of disease that is present at baseline and will be quantifiably measured.", "preferredTerm": "Measured Tumor Identification", "submissionValue": "MEASURED"}, {"conceptId": "C94522", "definition": "The identification of a tumor, lesion, or site of disease which has not been previously seen or characterized.", "preferredTerm": "New Lesion Identification", "submissionValue": "NEW"}, {"conceptId": "C103423", "definition": "The identification of a tumor, lesion, or site of disease that is incapable of being measured at baseline.", "preferredTerm": "Non-Measurable Tumor Identification", "submissionValue": "NON-MEASURABLE"}, {"conceptId": "C94521", "definition": "The identification of a tumor, lesion or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention.", "preferredTerm": "Non-Target Lesion Identification", "submissionValue": "NON-TARGET"}, {"conceptId": "C103425", "definition": "The identification of a tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured.", "preferredTerm": "Not Measured Tumor Identification", "submissionValue": "NOT MEASURED"}, {"conceptId": "C94520", "definition": "The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention.", "preferredTerm": "Target Lesion Identification", "submissionValue": "TARGET"}, {"conceptId": "C103442", "definition": "The identification of a tumor or lesion that is present at baseline, located outside of or independent of any lymph nodes, and is the target of the therapeutic intervention.", "preferredTerm": "Target Extra Nodal Tumor Identification", "submissionValue": "TARGET EXTRA NODAL"}, {"conceptId": "C103443", "definition": "The identification of a tumor or lesion located at or near the lymph node that is present at baseline and is the target of the therapeutic intervention.", "preferredTerm": "Target Nodal Tumor Identification", "submissionValue": "TARGET NODAL"}, {"conceptId": "C103444", "definition": "The identification of a nodule that is the target of the therapeutic intervention.", "preferredTerm": "Target Nodule Tumor Identification", "submissionValue": "TARGET NODULE"}]}